A deficiency in cathelicidin reduces lung tumor growth in NNK/NTHi-induced A/J mice

Area of Science:

• Immunology
• Oncology
• Molecular Biology

Background:

• Cathelicidin is an antimicrobial peptide involved in cell proliferation, angiogenesis, and tumor promotion.
• The precise mechanisms by which cathelicidin contributes to tumor growth, particularly through gain or loss of function, remain largely unelucidated.
• Understanding cathelicidin's role is crucial for developing targeted lung cancer therapies.

Purpose of the Study:

• To investigate the role of cathelicidin in lung cancer development and progression.
• To establish and utilize a novel knockout mouse model for studying cathelicidin's function in vivo.
• To elucidate the pathogenic mechanisms underlying cathelicidin-mediated tumor growth.

Main Methods:

• Generation of a cathelicidin related antimicrobial peptide (CRAMP) knockout mouse on an A/J background (A/J-CRAMP^-/-).
• Induction of lung carcinoma in A/J and A/J-CRAMP^-/- mice using 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and Non-typeable Haemophilus influenzae (NTHi).
• Assessment of tumor burden, survival rates, and proliferation markers (PCNA, Ki-67) and apoptosis in lung tissues.

Main Results:

• A/J-CRAMP^-/- mice exhibited significantly lower tumor burden and longer survival times compared to control A/J mice.
• A marked reduction in proliferating cell nuclear antigen (PCNA) and Ki-67 positive cells was observed in the knockout mice.
• No significant difference in the number of apoptotic lung cancer cells was found between the two groups, suggesting proliferation, not apoptosis, is affected.

Conclusions:

• Cathelicidin acts as a tumor growth factor in lung cancer, primarily by promoting tumor cell proliferation.
• The absence of CRAMP confers resistance to NNK/NTHi-induced lung carcinogenesis.
• The A/J-CRAMP^-/- mouse model provides a valuable tool for future research into cathelicidin's specific roles in lung cancer development.